KVUE
KVUEXNYS

Kenvue Inc.

Market cap $37.0B

$19.28

-3.08 (-13.77%)past year

KVUE

$19.28

+2.01% today

Market price$19.28
Shares1
Est. total$19.28

Buy with €1M virtual cash · No real money

Kenvue Inc. (KVUE) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates KVUE a Hold, with the stock down 14% over the past year. You can practice trading KVUE risk-free with €1,000,000 in virtual cash.

Key stats

As of July 27, 2026

Market Cap

$37.0B

Volume

21.4M

52-wk High

$22.74

52-wk Low

$14.02

Day High

$19.28

Day Low

$18.83

P/E (TTM)

22.68

Revenue (TTM)

$15.3B

EPS (TTM)

$0.85

Performance

1M

+2.6%

6M

+8.6%

1Y

-14.5%

Invest signal · KVUE

Hold
SellHoldBuy
1-year trend-14%
3-month momentum+10%
Valuation (P/E)22.7
Revenue growth (QoQ)+3.4%
Profitability (EPS)Profitable

Algorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.

KVUE overview

AI overview

Revenue & EPS — last 8 quarters

QoQ rev +3.4%

Revenue

$4B
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q4 '26

EPS (diluted)

$0.25 per share
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q4 '26

About Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health.

Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Employees

22,000

www.kenvue.com

30-Day Win Rate · KVUE

57%WIN RATE
Up days

13 days

Down days

10 days

Last 23 sessions

How to practice trading KVUE

  1. 1

    Use the KVUE buy panel above

    Set a quantity and hit Buy at the real market price — right here, nothing to download.

  2. 2

    Trade with €1,000,000 virtual cash

    You get a million in virtual money instantly to invest, risk-free.

  3. 3

    Create a free account to save it

    Sign up in seconds to keep your portfolio and track its performance.

  4. 4

    Track and compete

    Watch your portfolio grow and climb the global leaderboard — or start a private league.

  5. 5

    Prefer mobile? Get the iOS app

    Invest is also free on the App Store, synced with your web account.

Top KVUE traders on Invest

Full leaderboard
🥇Ben Carter+138.0%
🥈Michael T.+127.0%
🥉alex_wong+118.0%
#4james_doyle+106.0%
#5Henrik N.+97.0%

Frequently asked questions

Is KVUE a good stock to buy right now?

As of July 27, 2026, Invest's signal rates KVUE a Hold, based on its price trend, valuation, and fundamentals (P/E around 22.7), with the stock down 14% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading KVUE risk-free first.

What is Kenvue Inc.'s (KVUE) market cap?

Kenvue Inc. has a market capitalization of approximately $37.0B, on trailing-twelve-month revenue of about $15.3B.

How has KVUE stock performed?

KVUE is down 14% over the past year and up 9% over six months. Its 52-week range runs roughly from $14.02 to $22.74. Past performance doesn't predict future results.

How can I practice trading KVUE for free?

On Invest you get €1,000,000 in virtual cash and can buy KVUE at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.

More stocks to practice

Compare KVUE with peers

Invest — Stock Market SimulatorNot financial advice.